Abstract
The use and abuse of alcohol and nicotine are intimately related, with co-use of alcohol among adult cigarette smokers higher (>65%) than non-smokers (>45%), and smoking rates among alcoholics above 75%. Smoking is associated with an accelerated progression to alcohol dependence, suggesting that nicotine and alcohol act in a synergistic manner to promote coabuse. While recent work has begun to identify discrete 'neuronal ensembles' within stress and reward circuitry components that underlie nicotine's contribution to escalations in alcohol selfadministration, the neurobiological mechanisms facilitating alcohol-nicotine interactions following chronic drug exposure remain understudied. The goal of the current work was to identify a network of brain regions in mice that are activated differentially following chronic intermittent exposure to alcohol versus alcohol plus nicotine combinations via c-Fos immunoreactivity. Male C57BL/6J mice were systemically treated with either alcohol (1.5 g/kg) or a combination of alcohol plus nicotine (0.4, 0.8, or 1.2 mg/kg base) on a double-alternation schedule (drug, drug, saline, saline) for a 13-month period. Mice were euthanized 90-min following the final treatment, whole brains were removed and 40-µm coronal sections were evaluated for c-Fos immunoreactivity using established laboratory procedures. Co-administration of 0.4 and 0.8 mg/kg nicotine dose-dependently enhanced c-Fos immunoreactivity in the ventral tegmental area (VTA), centrally projecting Edinger-Westphal nucleus (cpEW), and the lateral septum (LS) when compared to alcohol only treated mice. In contrast, co-administration of 1.2 mg/kg resulted in a 33% decline in c-Fos labeled cells within the VTA, no change in LS activation, and comparable activation to 0.4 mg/kg nicotine in the cpEW. In summary, chronic intermittent nicotine exposure exacerbates the c-Fos response to alcohol in a dose-dependent and brain region-selective fashion. The nearly uniform, maximal response observed following 0.8 mg/kg nicotine across stress-and reward-associated brain regions is consistent with the ability of this dose to accelerate the progression towards excessive alcohol self-administration and to potentiate the discriminative stimulus effects of alcohol in rodents.
-Dedicated to my Dad -

Introduction
Alcohol & Nicotine
The use of Alcohol and Tobacco products has become a major public health concern in recent years. Nicotine specifically is the primary component in tobacco products that leads to drug dependence and reward. Alcohol and nicotine have pharmacological and neurological synergistic effects, resulting in various health problems such as cancers, vascular diseases, and gastric ulcers (Hurley, Taylor, & Tizabi, 2012) .
Widespread legalization and abundant availability plays a role in these most commonly abused substances, but genetic, rewarding, and analgesic properties of alcohol and nicotine also add to massive levels of use among the public. Alcohol and nicotine are often used simultaneously, especially among alcoholics, where smoking rates are estimated to be about twice as much as the general population in both adolescents and adults (Falk, Yi, & Hiller-Sturmhöfel, 2006) . This is a growing concern because traditional addiction research has only set out to study the effects of alcohol and nicotine separate from one another. This approach to addiction research does not accurately represent the way in which alcoholics and smokers consume these substances. In turn, the use of alcohol among adult cigarette smokers is relatively high (65.2%) compared to non-smokers (48.7%) (CDC, 2013) . Acute nicotine administration has also been shown to increase alcohol self-administration in non-dependent smokers, suggesting that nicotine dose can effect alcohol's interaction with the brain early in the process of addiction 2 (Barrett, Tichauer, Leyton, & Pihl, 2006) . The current research aims to address the question of how chronic, long term exposure, to alcohol and nicotine may influence the way these drugs are taken over time by creating a novel set of 'neuronal ensembles' that utilize previously associated mechanisms of addiction. With these questions in mind, knowing how various dosing levels of nicotine react with a consistent dose of alcohol can aid in finding the neurological mechanisms underlying co-abuse. Nicotine seems to prime the reward and stress system for alcohol, resulting in a greater amount of alcohol administration, and produces long lasting changes to signaling pathways (Doyon et al., 2013) . It is currently unclear as to how co-morbidity arises from the interaction of these two drugs, but further exploration of nicotine addiction can help reveal many aspects of drug dependence, especially in adolescents and people with mental illness, who are at higher risk for co-morbidity (Dani & Harris, 2005) . As a way to incorporate running hypotheses within the field of addiction research, the involvement of stress hormones and associated stress-hormone releasing structures within the brain are included in the analysis of 'neuronal ensembles', but it is still under investigation as to how exactly these stress pathways are influencing the neurology and behaviors of addiction. Stress-related hormones have been found to have lasting changes in dopamine and GABA neurotransmission, which are active components of the reward pathway (Walker et al., 2012 ). GABA acts primarily as an inhibitory neurotransmitter, with activation typically causing a decrease in neuronal excitability in the central nervous system (CNS), with notable building evidence to a possible link between the GABA type A (GABAA) receptor and the genetic component of alcoholism (Davies, 2003) . Alcohol acts partially on the GABAA receptors to enhance receptor activity and increasing the amount of Exploration of the basic mechanisms involved in co-abuse are needed before it can be fully understood as to how these neurotransmitters, receptors, and pathways are interacting with alcohol and nicotine. By studying the overlapping actions of alcohol and nicotine, valuable information about the co-abuse of many drugs of addiction can be revealed. These efforts lay down the groundwork for further research not only in the field of addiction, but for any study of neurological interactions and mechanisms. This approach can effectively narrow the direction of how treatments are used and made accessible for public use.
Animal Model of Co-Abuse
As a way of addressing issues in studying co-abuse, neurological activity must be examined to reveal specific areas of the brain that are most active when alcohol and nicotine are present. Although substance abuse is a human concern, using a suitable 4 animal model can provide valuable behavioral and neurological data on alcohol-nicotine interactions. It is unlikely that an exact representation of the complexity of human addiction can be reached using the animal model alone, but specific aspects can be revealed such as drug self administration, tolerance, sensitivity, and withdrawal (Balogh, Owens, Butt, Wehner, & Collins, 2002) . Procedures of self-administration have shown that rats will continually consume significant amounts of both alcohol and nicotine when made available, with levels of nicotine self-administration similar to rates of nicotine alone (Lê et al., 2010) . This research supports the important relationship between the two drugs, and the need to use animal models to ask basic questions about how are interacting. Animal models can be used as a way to address questions that both fully utilize the particular model and maximize results for comparison and analysis.
Mechanisms of Addiction
Abused drugs act on a series of neurological mechanisms within the brain, specifically the reward system. All individuals use the reward system every day for many aspects of life including eating, drinking, sex, and social engagement. The reinforcement of behaviors that are beneficial for survival are pleasurable to us because of the function of the reward system. We continue to partake in these activities because the neurological pathways are strengthened after each interaction, establishing a memory of reward. Drugs with chronic drug users, the brain begins to adapt to these changes. A patterned response is then established, which is referred to as neuroadaptation. The response from the brain is a developed tolerance, where the same doses of the drug no longer produce the same effect and larger doses are needed to get the desired gratification. Drugs of addiction will quickly rise to a top priority for users with a compromised reward system, because these drugs give greater pleasure than other activities. Over time, the dopamine receptors will become overstimulated and stop responding to the previous dose of the drug, which eventually leads to permanent damages to the way the brain functions in everyday activity.
The stress system adds an additional feature to the way drugs are delivering the experience of reward and pleasure. The hypothalamic-pituitary-adrenal (HPA) axis is 6 activated when our body naturally reacts to stress. The hypothalamus is a small structure that regulates the release of hormones from the pituitary gland. The release of hormones from the pituitary gland travel down the bloodstream to the kidneys and interact with the adrenal glands. The regulation of the stress response begins at the hypothalamus, where a hormone called corticotropin-releasing hormone (CRH) is released. CRH signals to the pituitary gland to secrete adrenocorticotropic hormone (ACTH) into the bloodstream, which travels down to the adrenal glands and signals the release of different steroid hormones depending on the site of activation. A class of hormones released from the outer (cortical) layer of the adrenal glands are called glucocorticoids, specifically cortisol, and they play and important role in stress, which increase blood sugar, suppress the immune system, and aid metabolism. ACTH also acts on the adrenal medulla (center of the adrenal gland) to trigger the release of epinephrine and norepinephrine, thereby increasing heart rate and alertness. Elevated cortisol levels in the bloodstream are sensed by glucocorticoid receptors in the hypothalamus that initiate a negative feedback response to counteract the stress response. This regulation via negative feedback allows for the regulation of cortisol to maintained at appropriate levels. Glucocorticoid receptors are also found in the midbrain, striatum, and cortical areas important for reward. It has been suggested that a nicotine and alcohol combination alters stress hormones in the early stages of drug intake and prime the system for negative emotional states, which are described as withdrawal (George F. Koob et al., 2014) . This further supports the idea that having a nicotine addiction (i.e. smoking cigarettes) can make a person more susceptible to drinking high amounts of alcohol.
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Neural Circuitry Underlying Alcohol and Nicotine Effects Alcohol (or ethanol specifically) is a dynamic drug that reacts with several brain functions. Generally, alcohol is known as a depressant that inhibits brain activity in the CNS. Alcohol interacts with GABA-A receptors to gate the amount of negatively charged ions (i.e., chloride) that are let into the cell. Chloride acts to inhibit the excitability of the neuron by causing hyperpolarization. For drinkers of alcohol, results of the interaction with GABA-A receptors produce calming and anxiolytic effects at low doses, but negative effects impair judgement and disrupt motor functions at higher doses. NMDA (glutamate) receptors, which are associated with the excitability of the neuron, are inhibited by alcohol by blocking the gating of sodium (Na+) and calcium (Ca+2) into cells. Nicotine is a psychostimulant that acts on acetylcholine receptors (nAChRs) to depolarize the neuron and increase excitability. Within the sympathetic nervous system nicotine increases blood pressure, heart rate, and the release of norepinephrine. Cigarette smokers experience effects of calmness, alertness, relaxation, but negative symptoms of craving, irritability, and impatience.
When these drugs are taken together, both biological and behavioral effects are altered. The complex phenotypes that are observed in addicted individuals vary depending on the drug(s) of choice, resulting in different neurological changes within these circuits. Although neuronal activation following alcohol or nicotine can be observed separately, the combination of the two drugs likely alters the way these pathways would function during single drug use (for instance, synergism or additivity) or involves activation of new pathways in the brain. To begin to understand how alcohol 8 and nicotine are interacting we must gain a perspective on previous addiction studies, findings, and definitions. A commonly accepted addiction model describes three progressive stages of the addiction that involve binge, withdrawal, and craving (G. F. Koob, 1997) . These stages have been associated with discrete circuits that incorporate specific neuronal structures that describe how theories of addiction can be applied to a variety of drugs. Ventral tegmental area (VTA) and ventral striatum are associated with binge, amygdala with withdrawal, and prefrontal cortex, basolateral amygdala, hippocampus, and insula with craving (G F Koob & Volkow, 2010) . Response to chronic exposure tends to be more restricted within certain brain regions in the case of alcohol.
On the other hand, consistent response from both chronic and acute treatments of alcohol are seen from lateral septum, edinger-westphal nucleus, and paraventricular nucleus of (Leão et al., 2015) . Drugs that replace the effects of alcohol or nicotine can help to determine what each substance is acting on receptors and interacting with each other. The influence of nAChR antagonist mecamylamine has been examined within operant selfadministration in C57BL/6J mice, and found a suppression in dose-dependent alcohol intake and change in locomotor activity (Ford et al., 2009) . Although more experiments 9 using drug substitutions still need to take place, the previous findings suggest that a map of the way in which nAChRs and neuronal activity function with the combination of alcohol and nicotine would be of valuable importance for addiction research.
c-Fos C-Fos is the cellular counterpart to a viral gene isolated in 1982 from FinkelBiskis-Jinkus osteogenic sarcoma virus, and is defined as a type of immediate-early gene (IEG) that rapidly responds to intracellular signaling (Sng, Taniura, & Yoneda, 2004) .
IEGs have been an important focus of the field of addiction research for over 20 years because administering drugs of addiction (chronic or acute) changes IEG expression, which can be used to measure the processes of addiction in a way that identifies druginduced neuroplastic changes (Kalivas et al., 2006) . Positive c-Fos activation has been identified using immunocytochemistry to reveal effects of nicotine on brain regions related to stress, suggesting they could be mediating the effects of nicotine on the central nervous system (CNS) (Matta, Valentine, & Sharp, 1997) . C-Fos can be stained in the brain by using an antibody to reveal the regions activated prior to mice being euthanized.
We would expect the traditional reward and stress regions to be active, but c-Fos can reveal new areas of activation and significant suppression or expression differences in varied doses.
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Research Question
How does chronic intermittent administration of alcohol and alcohol-nicotine combinations change the amount of brain activation in the male C57BL/6J mouse brain?
Hypothesis
It was hypothesized that the combined effects of alcohol and nicotine would produce brain activation in stress and reward related areas, with the combined alcoholnicotine dosing (fixed alcohol dose plus low, medium or high dose nicotine) showing a difference in activation compared to the saline or alcohol only control groups. 
Dosing & Treatment
Mice groups were administered a fixed alcohol dose (1.5 g/kg) or one of three combinations of alcohol + nicotine. Treatment groups were as follows: 1.5 g/kg alcohol (1.5E) alone, 1.5 g/kg alcohol + 0.4 mg/kg nicotine (1.5E + 0.4N), 1.5 g/kg + 0.8 mg/kg nicotine (1.5E + 0.8 N), and 1.5 g/kg alcohol + 1.2 mg/kg nicotine (1.5E + 1.2N). Fixed ratio schedule (FR) was used as a form of operant conditioning that provided reinforcement after a specified number of responses. Once the mice were trained, the mice were divided into separate groups and given an intraperitoneal (i.p.) injection of either the saline, alcohol, or nicotine-alcohol combination (Ford et al., 2012) . A double-14 alternation schedule of drug administration was used where saline (i.e., non-drug) was given two days in a row and then alcohol or both drugs for two days (saline, saline, drug, drug). Each group of mice were required to meet criteria for drug discrimination for three days prior to and including the final testing session, the last requirement that the mice needed to demonstrate criteria on the test session that day in order to be euthanized (see Ford et al., 2012 for additional details). To avoid disruptions in home cage environments, both mice (housed in pairs) were required to meet criteria on the same day. Each group (n=12) was divided into sub-groups (n=6) that were balanced with a four day mean according to total responses from both levers (activity measure), initial FR accuracy (% appropriate responding), and body weight (training sessions only; test sessions not included). The time of day, handling, and transportation were all taken in to consideration during the procedure for final testing, as to not disrupt normal occurrences in the home cage. Individual mice were injected with treatment dose according to sub-group and placed into the operant chamber for 10-min pretreatment. Following pretreatment, the house light turning on and the test session began for the standard 15 min sessions. The mice were then returned to their home cage and fed their daily food diet, and remained in the procedural room for another 55 min before being transported to a separate procedural room where they were placed in a CO2 chamber. At 90 min total after initial treatment injection mice were euthanized (Ford et al., 2012) . Normally, a perfusion of paraformaldehyde (PFA) is used to preserve the tissue and organs of the mouse, but in this particular procedure PFA was not used because it can prevent the primary antibody (c-Fos) from binding properly. The whole brain was isolated in a time sensitive manner (about 12ml of fixative tissue) and placed into a cold a 2% paraformaldehyde buffer. The 15 brains can then be cryoprotected and stored for up to year or more. When brains are ready to be sliced they are placed on a fixative mount, covered with a thin layer of Optimal Cutting Medium (OCT), and frozen before being cut into slices 30-40 microns thick.
After the slices are placed into net wells they are stained with the primary antibody (cFos), washed, and dried before coverslipping with cryoseal (Ryabinin, Criado, Henriksen, Bloom, & Wilson, 1997) . The final product of this procedure allows for the stained brain slices to be viewed under a microscope for comparison and analysis.
Imaging & Counting Cells
An initial global examination of the mouse brain slides was taken using a light microscope and a mouse brain atlas. This allowed for an unbiased look at c-Fos activation throughout different sections of the brain. Certain areas with staining that could be seen easily with the naked eye stuck out immediately, but it was still difficult to get an accurate count of cell activation (ranging from 10-2000 cells) along with having a way to to detect the variations in size, shape, and clarity of the stained cells. The traditional method for counting cells, done by hand, would not provide a reliable count of the cells that were stained on each slide and because some sections contained thousands of cells, we needed an accurate way to measure and analyze these cell populations for statistical comparison. To best examine each brain slice, digitalized each of the slices using a light microscope and a camera (mounted on top). 
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The background image and the ROI image was opened in ImageJ, and the background was subtracted. A new black and white ROI image was then generated to allow for a noise free analysis of the stained cells. The threshold tool within ImageJ was adjusted to fill up of the cell bodies, and a standard threshold criteria was established (10-110 pixels^2). A free hand selection method and a mouse brain atlas was used to select the ROI within the image to adjust for the size variance between brain slices and regions. After selecting the ROI, everything outside the selection was cleared and an analysis of the cell particles were run using ImageJ tools. Low statistical power (n=5-6 mice per group) in this study compared with other studies using higher populations of mice (8-12 mice per group) can contribute to the lack of significant changes of activation between groups.
Conclusions
Addiction research has come a long way in recent years, with new methods and approaches being developed constantly. As we gain a basic understanding of the neurobiology of addiction, new questions arise at every turn. Polysubstance abuse, particularly the interactions of alcohol and nicotine have major gaps that must be 24 addressed by the scientific community. There is an obvious social concern with rates of comorbidity as high as 92% in people with alcohol use disorders (AUDs) (Gold, 1998) .
The main pharmacotherapeutic strategies do not reflect the way in which drugs are used in our society today, but focus on reducing either alcohol or nicotine use separately.
None of these individual pharmacological options have proven to have the wide success that in needed to have any significant impact. People use drugs of abuse for a large variety of reasons and therapies should have a similar kind of a approach to essentially tailor to individual needs. The current research has aimed to model a chronic user of both alcohol and nicotine. Because of this, subpopulations of drug users at different stages of addiction may have an entirely different set of effects, as would be expected. Although recognizing the way in which a chronic user is functions can help identifying the discrete 'neuronal ensembles' of activation to seek out and observe in the future. The types of activation found in this study has shown a wide variety of regions that are incorporated when both alcohol and nicotine are present, but this could lead to a specific narrative that can be linked together. In addition to using knowledge of the reward system recent work has incorporated the stress system to aid in piecing together the mechanisms in facilitating the escalation of alcohol drinking with chronic nicotine users (Leão et al., 2015) . With more researchers asking new questions and conducting alternative methods to studying addiction the sense of breaking through the barriers of past approaches and finding useful therapeutic treatments is that much closer to realization.
